FIELD: medicine.
SUBSTANCE: invention represents a method for the differential diagnostics of hepatic steatosis and steatohepatitis by biochemical tests characterised by measuring blood serum phospholipase A2, nitrogen oxide and endotoxin; if phospholipase A2 is 199.7-252.5 ng/ml, nitrogen oxide is 93-94.6 mcmole/l and endotoxin is 2.2-2.6 EU/ml, hepatic steatosis is diagnosed; if phospholipase A2 is 412.5-576.5 ng/ml, nitrogen oxide is 137.5-168.5 mcmole/l and endotoxin is 3.32-4.18 EU/ml, steatohepatitis is diagnosed.
EFFECT: higher accuracy of differential diagnostics and reduced analysis injuries.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING RISK OF ISCHEMIC HEART DISEASE | 2013 |
|
RU2532361C1 |
METHOD FOR ASSESSING CLINICAL EFFECTIVENESS IN IRRITABLE BOWEL SYNDROME ACCOMPANIED BY DIARRHOEA | 2014 |
|
RU2570767C1 |
METHOD OF LACTASE DEFICIENCY IN ADULTS TREATMENT | 2017 |
|
RU2684099C1 |
METHOD OF DIAGNOSING THE SEVERITY OF IRRITABLE BOWEL SYNDROME | 2017 |
|
RU2668496C2 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2013 |
|
RU2537229C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE | 2011 |
|
RU2473342C1 |
METHOD OF TREATING CHRONIC CONSTIPATION AND FUNCTIONAL ANOREXIA | 2013 |
|
RU2545988C1 |
METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND TYPE 2 DIABETES MELLITUS | 2018 |
|
RU2706026C1 |
DIAGNOSTIC TECHNIQUE FOR ASYMPTOMATIC CELIAC DISEASE IN ADULTS | 2020 |
|
RU2747523C1 |
METHOD FOR IBS-SIMILAR SYNDROME DIAGNOSTICS WITH ULCERATIVE COLITIS | 2016 |
|
RU2649468C2 |
Authors
Dates
2015-04-10—Published
2013-07-16—Filed